| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.9M | -11.6% |
| SG&A Expense | $19.7M | -9.2% |
| Operating Income | -$67.6M | +10.9% |
| Net Income | -$62.7M | +16.1% |
| EPS (Basic) | -$2.25 | +16.4% |
| EPS (Diluted) | -$2.25 | +16.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.1M | -50.9% |
| Current Assets | $112.7M | -31.3% |
| Total Assets | $128.0M | -30.5% |
| Current Liabilities | $6.9M | -24.6% |
| Total Liabilities | $13.6M | -18.1% |
| Stockholders' Equity | $114.4M | -31.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.0M | +1.7% |
| Capital Expenditures | $820K | -61.2% |
| Investing Cash Flow | $39.3M | -42.2% |
| Financing Cash Flow | $154K | -23.0% |
| Free Cash Flow | -$53.8M | +3.9% |